Analysis tumor
CPT 88358 covers computer-assisted analysis of tumor characteristics using specialized imaging technology to measure and assess tumor cells from tissue samples.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify the morphometric analysis uses computer-assisted technology rather than manual counting or visual estimation, as only computerized quantitative analysis qualifies for 88358
Impact: Prevents 100% claim denial and potential fraud allegations; manual methods require different coding
Document the specific morphometric parameters measured (e.g., nuclear area, chromatin density, architectural features) and the computer system used in the pathology report
Impact: Reduces denial rate by 40-60% and supports medical necessity during audits
Bill 88358 only once per tumor site analyzed, regardless of the number of parameters measured or images analyzed from that site
Impact: Prevents overbilling denials; multiple tumor sites may justify separate units with modifier 59/XU and documentation
Ensure the morphometric analysis is ordered separately or documented as medically necessary beyond routine pathologic examination (88305-88309)
Impact: Establishes medical necessity and prevents bundling denials with surgical pathology codes, protecting the full $130.68 reimbursement
When billing with special stains or immunohistochemistry, verify payer-specific policies on bundling as some payers consider morphometric analysis inclusive
Impact: Proactive policy review prevents $130.68 denial or recoupment on 20-30% of claims with complex staining
For Medicare, confirm the morphometric analysis meets LCD/NCD requirements for the specific tumor type and clinical indication before performing
Impact: Prevents medical necessity denials; some tumor types have limited coverage resulting in potential $130.68 write-off per case
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.